바로가기메뉴

본문 바로가기 주메뉴 바로가기

Tuberculosis & Respiratory Diseases

Article Contents

Prev Next
e-Submission

Vol.75 No.4
Citation Share

Intrapleural Corticosteroid Injection in Eosinophilic Pleural Effusion Associated with Undifferentiated Connective Tissue Disease

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2013, v.75 no.4, pp.161-164






& (2013). Intrapleural Corticosteroid Injection in Eosinophilic Pleural Effusion Associated with Undifferentiated Connective Tissue Disease. Tuberculosis & Respiratory Diseases, 75(4), 161-164.
  • Downloaded
  • Viewed
PDF Download

Abstract

Eosinophilic pleural effusion (EPE) is defined as a pleural effusion that contains at least 10% eosinophils. EPE occurs due to a variety of causes such as blood or air in the pleural space, infection, malignancy, or an autoimmune disease. Undifferentiated connective tissue disease (UCTD) associated with eosinophilic pleural effusion is a rare condition generally characterized by the presence of the signs and symptoms but not fulfilling the existing classification criteria. We report a case involving a 67-year-old man with UCTD and EPE, who has been successfully treated with a single intrapleural corticosteroid injection.

keywords
Pleural Effusion, Instillation, Methyprednisolone, Eosinophilia, Connective Tissue Diseases

Reference

1.

Kalomenidis I, Light RW. Eosinophilic pleural effusions. Curr Opin Pulm Med 2003;9:254-60.

2.

Ishiura Y, Fujimura M, Nakamura N, Jokaji H, Minami S, Matsuda T. Intrapleural corticosteroid injection therapy for post-traumatic eosinophilic pleural effusion. Respir Med 1996;90:501-3.

3.

Rubins JB, Rubins HB. Etiology and prognostic significance of eosinophilic pleural effusions: a prospective study. Chest 1996;110:1271-4.

4.

Mosca M, Tani C, Carli L, Bombardieri S. Undifferentiated CTD: a wide spectrum of autoimmune diseases. Best Pract Res Clin Rheumatol 2012;26:73-7.

5.

Maeshima E, Nishimoto T, Yamashita M, Mune M, Yukawa S. Progressive systemic sclerosis-polymyositis overlap syndrome with eosinophilic pleural effusion. Rheumatol Int 2003;23:252-4.

6.

Ferreiro L, San Jose E, Gonzalez-Barcala FJ, Alvarez-Dobano JM, Golpe A, Gude F, et al. Eosinophilic pleural effusion: incidence, etiology and prognostic significance. Arch Bronconeumol 2011;47:504-9.

7.

Oba Y, Abu-Salah T. The prevalence and diagnostic significance of eosinophilic pleural effusions: a meta-analysis and systematic review. Respiration 2012;83:198-208.

8.

Krenke R, Nasilowski J, Korczynski P, Gorska K, Przybylowski T, Chazan R, et al. Incidence and aetiology of eosinophilic pleural effusion. Eur Respir J 2009;34:1111-7.

9.

Samman YS, Wali SO, Abdelaal MA, Gangi MT, Krayem AB. Chronic eosinophilic pneumonia presenting with recurrent massive bilateral pleural effusion: case report. Chest 2001;119:968-70.

10.

Breuer GS, Deeb M, Fisher D, Nesher G. Therapeutic options for refractory massive pleural effusion in systemic lupus erythematosus: a case study and review of the literature. Semin Arthritis Rheum 2005;34:744-9.

11.

Felz MW, Haviland-Foley DJ. Eosinophilic pleural effusion due to dantrolene: resolution with steroid therapy. South Med J 2001;94:502-4.

12.

Cavazzana I, Franceschini F, Belfiore N, Quinzanini M, Caporali R, Calzavara-Pinton P, et al. Undifferentiated connective tissue disease with antibodies to Ro/SSa: clinical features and follow-up of 148 patients. Clin Exp Rheumatol 2001;19:403-9.

Tuberculosis & Respiratory Diseases

e-Submission OA Policy